Annual Progress Report 2021
Welcome to Gavi’s 2021 Annual Progress Report, the first of the 2021–2025 strategic period.
TOGETHER WE HAVE ACHIEVED, 2000-2021
Progress seen in 2021 is a testament to the power of the vaccine alliance
Since Gavi was established in 2000, in its mission to save lives, reduce poverty and protect the world against the
threat of epidemics and pandemics has helped vaccinate more than 981 million children in 73 countries through the end of 2021 – preventing more than 16.2 million future deaths.
The progress seen in 2021 is a testament to the power of the Vaccine Alliance – from our core partners to the dedicated, passionate people in countries and communities upon whose hard work and expertise we rely every day to protect the next generation.
As we stand side by side with countries to battle COVID-19, the Alliance maintains a relentless focus on keeping immunisation programmes running, to ensure the pandemic leaves no one behind – especially the 12.5 million zero-dose children who did not receive a single shot of basic vaccines in 2021.
As the core of Gavi’s work, life-saving immunisation represents a beacon of hope in these uncertain times: the foundation for the healthy future every child deserves, and on which our interconnected world depends.
Highlighting key data, partnerships and milestones, the 2021 Annual Progress Report offers insights into our progress last year, while facing the challenges ahead – including the Vaccine Alliance’s role in the global COVID-19 response.
Past progress reports
View allWelcome to Gavi’s 2024 Annual Progress Report, the fourth of the 2021–2025 strategic period.
Welcome to Gavi’s 2023 Annual Progress Report, the third of the 2021–2025 strategic period.
Welcome to Gavi’s 2022 Annual Progress Report, the second of the 2021–2025 strategic period.
Welcome to Gavi’s 2021 Annual Progress Report, the first of the 2021–2025 strategic period.
Welcome to Gavi’s 2020 Annual Progress Report, the fifth in a series of five covering this strategic period.
Welcome to Gavi’s 2019 Annual Progress Report, the fourth in a series of five covering this strategic period.
In this edition of our Annual Progress Report, we look back at the third year of the 2016-2020 strategic period and provide a global context for the work of the Vaccine Alliance.
The annual progress report gives a comprehensive overview of the activities and performance of the Gavi Alliance, illustrating the work and achievements of this public-private partnership.
The annual progress report gives a comprehensive overview of the activities and performance of the Gavi Alliance, illustrating the work and achievements of this public-private partnership.
Marking the end of GAVI's first decade, the 2010 Progress Report shows how unprecedented demand, accelerated access to vaccines and strong country ownership have helped save over five million future deaths.
GAVI's 2009 Progress Report paints a picture of developing country commitment and ownership of GAVI programmes. By the end of the year, over 250 million additional children had been vaccinated through GAVI support.
By the end of 2008, 3.4 million future deaths have been averted through GAVI support for vaccines. In 2008, GAVI undergoes governance and administrative changes, becoming a Swiss international organisation.
2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.
Gavi Progress Report 2007 Summary
2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.
This report for 2006 is the first of the new 10-year phase of operations which will take us to 2015 and beyond.
In the first five years of GAVI, 15 million more children were reached with basic vaccines, 99 million were reached with new vaccines and 1.2 billion auto-disable syringes were delivered.
After five years in operation, 71 countries out of 75 GAVI-eligible countries have received GAVI support, with one third of resources directed toward strengthening health systems in poorest countries.
Related articles
Gavi’s impact in 2024 in seven key statistics
In the time it takes you to read this article, six people’s lives will have been saved by Gavi-supported vaccines. Here are seven statistics on Gavi’s impact in 2024.
Prof José Manuel Barroso, Chair of the Gavi Board, and Dr Sania Nishtar, CEO of Gavi since 18 March 2024, reflect on the driving forces of progress in 2023 and plans for 2024.
Gavi's impact in 2023 in seven key statistics
In the time it takes you to read this article, six people’s lives will have been saved by Gavi-supported vaccines. Here are seven statistics on Gavi’s impact in 2023.
Gavi’s impact on the world in 2022: 7 key statistics
Gavi’s 2022 Annual Progress Report highlights the impact of investment in immunisation across 57 Gavi-supported countries.
On the road to recovery in 2022, a year of renewal in 2023
Prof José Manuel Barroso, Chair of the Gavi Board, and Gavi CEO (ad int) David Marlow on achievements and challenges in 2022, and priorities and goals for 2023.
APR 2021: 1.2 million future deaths prevented, 65 million children newly protected
Gavi’s 2021 Annual Progress Report, released today, is a record in numbers of another difficult pandemic year – a year of alarming setbacks, and a year of hard-won gains.
APR 2021: Recognising country commitment
Prof José Manuel Barroso, Chair of the Gavi Board, reflects on the achievements of lower-income countries during the pandemic.
APR 2021: Reflecting on 2021, the global imperative for 2022
Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, looks back on the first year of Gavi 5.0
Five crucial years, one unprecedented new pandemic and 324 million children immunised
Even with the adversities and challenges of the COVID-19 pandemic through 2020, Gavi maintained unyielding focus on leaving no one behind.
Routine immunisation worldwide holds firm despite the pandemic
Despite the havoc wrought by the COVID-19 pandemic on health systems worldwide, governments’ work to bring immunisation programmes back on track is paying off.
Empowering countries to self-finance vaccines
A growing number of countries are transitioning out of Gavi support. Here’s how we help them sustainably finance and manage their vaccine programmes over the long term.
New vaccines to meet emerging needs
Here’s how Gavi helps lower-income countries get the new vaccines and products they need to address urgent threats to public health – from cholera and COVID-19, to Ebola and pneumonia.
Strengthening supply chains: a long-term investment
The Vaccine Alliance has been working hard in recent years to build greater resilience in supply chains, an effort that is starting to show results.
Children who get zero vaccines deserve 100% of our attention
Over 50% more children were immunised in Gavi countries in 2019 than in 2000, yet 10.6 million children continue to miss out entirely on basic vaccinations. Here’s why reaching these children and setting them on the pathway to full immunisation…
Boosting demand for immunisation
Building and maintaining demand for immunisation is an integral part of Gavi’s work to increase coverage and equity. Here’s an insight into how we have achieved this.
How innovative finance can fight deadly diseases
One of the vital components to Gavi’s capital structure is the International Finance Facility for Immunisation (IFFIm). A powerful and award-winning financial tool launched in 2006, IFFIm issues Vaccine Bonds on the capital markets against long-…
Taking the long view on vaccine markets
Gavi’s long-term approach to developing healthy markets for critical vaccines has led to greater stability and security, providing countries with the confidence that supplies will be available to meet their demand.
2019 was a landmark year for countries co-financing their vaccine programmes
In 2019, a higher share of Gavi-supported countries than ever before met their co-financing obligations on time, thanks to strong political commitment.
Strong systems for strong vaccine coverage
In 2019, countries delivered more than 230 million routine vaccinations, a record number, supported by unprecedented levels of health system funding from Gavi to support immunisation and protect the most vulnerable children. Here is what Gavi did…
How good quality data is vital to saving lives
Throughout the 2016–2020 strategic period, the Vaccine Alliance has worked with countries to improve data quality. From GIS to SMS, new tech and tools aim to reach more people with life-saving immunisation.
How Gavi’s co-financing model works
To bring countries on a trajectory towards financial sustainability, and to empower them to take ownership of their vaccination programmes, Gavi has pioneered an approach to co-financing and transition.
Download for life: a mobile app to improve vaccine coverage in Côte d’Ivoire
Gavi's partnership with telecoms provider Orange and the Ministry of Health overcomes barriers to childhood immunisation through tailored, tested technology.
The benefits of immunisation extend beyond preventing childhood deaths. Vaccines are also a vital tool in the fights against cancer, outbreaks and antimicrobial resistance.
The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.
Experimental approaches to address post-transition risks
After transitioning out of Gavi support in 2017, the Republic of Moldova is mobilising champions and advocates to strengthen vaccine confidence – which is crucial to the success and sustainability of immunisation programmes.
Typhoid: immunising against antimicrobial resistance
Typhoid fever is increasingly resistant to the main antibiotics used to treat it. Gavi is supporting a new vaccine to help control this deadly disease – and fight antimicrobial resistance.
Leaders in the fight against infectious diseases
Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.
How health systems work and why they matter
Supporting health systems is essential for Gavi’s work to improve immunisation coverage and equity.
Resilience and the risks to global health security
When disaster strikes a country, the impact on people’s health can be immense and long-lasting. As the effects of climate change are felt around the world through rising temperatures and sea levels, natural disasters are increasingly frequent and…
Vaccines are the best tools yet invented to prevent child deaths and protect people’s health. Gavi funding for access to vaccines has protected a generation of children growing up in lower-income countries. Gavi funds twin approaches to…
A record-breaking year for childhood immunisation
Gavi’s CEO provides an overview of its flagship publication, launched today.
Last updated: 8 Dec 2022